IHI

iShares U.S. Medical Devices ETF

iShares' medical-devices fund, concentrated in the mapped device and diagnostic leaders.

Research reviewed
Oct 14, 2026
Mapped companies
16
Holdings as of
Oct 26, 2026

Fund summary

Strategy

iShares' medical devices ETF — the Healthspan Intervene-layer lens on devices and diagnostics (Abbott, Intuitive Surgical, Medtronic).

Stated focus

Healthspan mapped companies, as held by the IHI issuer file.

Read full strategy

iShares U.S. Medical Devices ETF (IHI) is a passively managed fund issued by iShares, the ETF franchise of BlackRock. It tracks the Dow Jones U.S. Select Medical Equipment Index, a benchmark of U.S. companies that manufacture and distribute medical devices, instruments, and diagnostics. IHI is the Healthspan "intervene" lens on devices and diagnostics: its mapped positions are anchored by Abbott, Intuitive Surgical, and Medtronic, spanning the tools used to diagnose, monitor, and intervene in human health. In the PXS map, IHI expresses the Healthspan universe's device-and-diagnostic layer, distinct from IBB's therapeutic tilt and ARKG's tools-and-sequencing concentration. Coverage is limited to direct, issuer-reported positions in already-mapped companies, not the complete portfolio, and this is a research map rather than a recommendation. IHI is most useful for seeing where the largest medical-device vehicle's index weight lands across the mapped Healthspan device companies. Its largest mapped positions are Abbott (17.7%), Intuitive Surgical (15.38%), Medtronic (11.63%), and ResMed (4.59%) — a heavy large-cap concentration in the mapped device-and-diagnostic leaders.

Top 10 holdings

As of Oct 26, 2026. Top holdings by weight among U.S.-listed issuers (stockanalysis.com); non-U.S.-listed positions may be omitted. Portfolio weights are not ownership percentages of the companies.

#CompanyTickerPortfolio weight
1Abbott Laboratories MappedABT17.46%
2Intuitive Surgical, Inc. MappedISRG15.55%
3Medtronic plc MappedMDT11.36%
4ResMed Inc. MappedRMD4.78%
5Stryker Corporation MappedSYK4.72%
6Becton, Dickinson and Company MappedBDX4.68%
7IDEXX Laboratories, Inc.IDXX4.60%
8Edwards Lifesciences Corporation MappedEW4.37%
9Boston Scientific Corporation MappedBSX4.30%
10GE HealthCare Technologies Inc. MappedGEHC4.23%

Known positions in mapped companies

CompanyRelationshipPortfolio weightAs ofEvidence
BAXTER INTERNATIONAL INCReported holding1.71%Oct 26, 2026Source
Zimmer BiometReported holding2.46%Oct 26, 2026Source
TransMedicsReported holding0.32%Oct 26, 2026Source
StrykerReported holding4.72%Oct 26, 2026Source
ResMedReported holding4.78%Oct 26, 2026Source
MedtronicReported holding11.36%Oct 26, 2026Source
iRhythmReported holding0.52%Oct 26, 2026Source
Intuitive SurgicalReported holding15.55%Oct 26, 2026Source
InsuletReported holding1.35%Oct 26, 2026Source
Globus Medical IncReported holding1.19%Oct 26, 2026Source
GE HealthCareReported holding4.23%Oct 26, 2026Source
Edwards LifesciencesReported holding4.37%Oct 26, 2026Source
DexcomReported holding3.85%Oct 26, 2026Source
Boston ScientificReported holding4.30%Oct 26, 2026Source
Becton DickinsonReported holding4.68%Oct 26, 2026Source
Abbott LaboratoriesReported holding17.46%Oct 26, 2026Source

Derived exposure

Counts cover distinct mapped companies only. They are not an allocation and do not describe the full portfolio.

Universes

Layers

Timeline

  1. May 1, 2006

    iShares U.S. Medical Devices ETF begins operations

    Source

Start here

  • Top mapped weights: ABT 17.7%, ISRG 15.38%, MDT 11.63%, RMD 4.59%.
Official portfolio / fund page

Open questions

  • How does this fund's active/passive weighting compare to peers in the same universe layer?

Sources

The weekly brief

Get a weekly digest of what’s changing.

Research updates, thesis changes and company developments. One email a week.